Ibuprofen for COVID-19 symptoms?

Prof Parastou Donyai

writer

Prof Parastou Donyai

Professor and Director of Pharmacy Practice, University of Reading

Prof Parastou Donyai

There’s been some confusion recently on whether we should or shouldn’t take ibuprofen to treat symptoms of COVID-19 – especially after the World Health Organization (WHO) changed its stance. After initially recommending people avoid taking ibuprofen to treat symptoms of the new coronavirus disease, as of March 19 the WHO now does not recommend avoiding ibuprofen to treat COVID-19 symptoms.

The confusion began after France’s Minister of Solidarity and Health Oliver Véran announced on Twitter that taking anti-inflammatory drugs (such as ibuprofen or cortisone) could be a factor in worsening a COVID-19 infection. He recommended that paracetamol should be taken instead to treat the associated fever.

At the moment, the NHS only recommends taking paracetamol for COVID-19 symptoms, even though it admits there is no strong evidence showing ibuprofen worsens symptoms. The BMJ also states that ibuprofen should be avoided when managing COVID-19 symptoms.

PASSWORD RESET

Forgot your password or password not working? Please enter your email address. You will receive an email with the link to set a new password.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Marie-Claire Seeley

Dr Marie-Claire Seeley

Postural Orthostatic Tachycardia Syndrome in Women

Dr Charlotte Hespe & Dr Ramy Bishay

Dr Charlotte Hespe & Dr Ramy Bishay

Panel Discussion on The Role of GLP-1 in the Management of CKD in T2D

Dr Anthony Chitti

Dr Anthony Chitti

Big Heads & Small Heads

Dr Sam Mehr

Dr Sam Mehr

Peanut Allergy

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Upcoming Healthed Webcast

Panel Discussion on The Role of GLP-1 in the Management of CKD in T2D

Tuesday 17th March, 7pm - 9pm AEDT

Speakers

Dr Charlotte Hespe & Dr Ramy Bishay

General Practitioner & Endocrinologist

Join Dr Charlotte Hespe and Dr Ramy Bishay for this expert panel webcast presentation, where they will discuss the role of GLP-1 in the management of CKD in T2D.